CPT code 86215 denotes an immunoassay performed on serum to detect antibodies to deoxyribonuclease (anti–DNase). This serologic test aids clinical evaluation for infectious and autoimmune conditions where anti–DNase antibodies are relevant. Nationally, serologic assays like this are part of laboratory diagnostic workflows that inform clinical decisions and downstream care.

Key payers considered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical purpose and typical laboratory setting for CPT code 86215, along with payer coverage context. The publication outlines expected benchmarks for utilization and reimbursement where available, summarizes relevant coding and billing considerations, and provides clinical context to help clinical laboratories and billing staff categorize the service correctly.

The analysis emphasizes practical information: what the code represents, typical sites of service, and how major payers approach coverage. Data not provided in the input—such as specific reimbursement rates, associated taxonomies, and ICD-10 mappings—is noted as unavailable. The section that follows provides a focused overview for quick reference by billing professionals and laboratory managers.